Published 8th August, 2003
Today [08.08.2003] the Lancet is publishing a paper by Professor Valerie Beral et al revealing the first results from the Million Women study. The study confirms that current and recent use of HRT can increase a woman's chance of developing breast cancer.
The study, funded by Cancer Research UK, the NHS Breast Screening Programme and the Medical Research Council, also found that:
- Current users of HRT are at a 22 per cent relative increased risk of death from breast cancer compared with never-users.
- The relative risk of breast cancer varied significantly among three HRT types and was substantially greater in users of oestrogen-progestogen combinations than other preparations.
- Use of HRT by women aged 50-64 years in the UK over the past decade has resulted in an estimated 20,000 extra breast cancers, of which 15,000 are likely to be associated with oestrogen-progestogen HRT.
For further information please visit the Million Women Study website.
The NHS Cancer Screening Programmes are not responsible for the content of external Internet sites.
- NHSBSP home page
- Programme publications
- About breast screening
- What is breast screening?
- What does the NHS Breast Screening Programme do?
- When was the NHS Breast Screening Programme set up?
- What happens at a breast screening unit?
- Why are women under 50 not routinely invited?
- Are women screened over the age of 70?
- Does breast screening save lives?
- Does breast screening have any risks?
- What is Digital Mammography?
- Research in breast screening
- About breast cancer
- Programme logistics
- Frequently asked questions
- Programme statistics
- Mammography equipment reports
- Programme news index
- Useful links